These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 121706

  • 1. Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
    Lander CM, Lees A, Stern G.
    Clin Exp Neurol; 1979; 16():197-203. PubMed ID: 121706
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. (-)Deprenyl in the treatment of decompensated Parkinson's disease.
    Csanda E, Tárczy M, Takáts A.
    J Neural Transm Suppl; 1986; 22():247-52. PubMed ID: 3097259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
    Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Bihari K.
    Adv Neurol; 1984; 40():549-56. PubMed ID: 6421113
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current controversies in the use of selegiline hydrochloride.
    Lees AJ.
    J Neural Transm Suppl; 1987; 25():157-62. PubMed ID: 3123602
    [Abstract] [Full Text] [Related]

  • 15. The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor.
    Przuntek H, Kuhn W.
    J Neural Transm Suppl; 1987; 25():97-104. PubMed ID: 3123607
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD, Delgado MR.
    Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 19. (-)Deprenyl in Parkinson's disease: a two-year study in the different evolutive stages.
    Giovannini P, Martignoni E, Piccolo I, Pacchetti C, Grassi MP, Nappi G, Caraceni T.
    J Neural Transm Suppl; 1986 Jan; 22():235-46. PubMed ID: 3097258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.